AI-assisted content review ensures alignment with brand, medical, legal, and regulatory standards in days, not months:
A stealth-stage AI startup set out to transform one of pharma’s most complex bottlenecks: Medical, Legal, and Regulatory (MLR) content review. With interest from top 10 global pharma companies, the opportunity was clear—speed up the review of marketing and medical content without compromising compliance.
We helped this emerging team define and validate an AI assistant that understands brand guidance, flags risk-prone language and suggests compliant alternatives. Designed to plug into existing platforms like Veeva or Zinc, the tool enhances—not replaces—the human review process.
In just 10 weeks, we delivered a validated UX model that included real-time claim classification, reference suggestions, and user feedback loops to improve accuracy over time. The result? A frictionless experience that shortens review cycles from three months to just days, improves consistency across brands, and positions the company for enterprise-scale adoption.